SCHEMBL2805783

SCHEMBL2805783

c1ccc2c(c1)-c1nc(N3CCN(c4cnccn4)CC3)ncc1CC21CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 3/20 0.36
CYP3A4 P08684 3/20 0.36
CYP2D6 P10635 3/20 0.36
TSHR P16473 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 2/20 0.36
USP2 O75604 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
MEN1 O00255 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SORD Q00796 1/20 0.34
DRD4 P21917 1/20 0.34
POLB P06746 1/20 0.34
SLC6A7 Q99884 1/20 0.34
PLD1 Q13393 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805444 0.83 ADRB2 (0.41) CYP3A4
SCHEMBL2805621 0.82 ALDH1A1 (0.40) ALDH1A1HSD17B10CYP3A4CYP2D6TSHR
SCHEMBL2804732 0.81 ADRB1 (0.52) ALDH1A1SMN1; SMN2CYP2C9KMT2APOLB
SCHEMBL2805183 0.80 SIGMAR1 (0.44) ALDH1A1SMN1; SMN2CYP2C19KMT2ALMNA
SCHEMBL2803911 0.79 HTR3A (0.35) ALDH1A1HSD17B10CYP3A4TSHRHPGD
SCHEMBL2803304 0.79 DRD4 (0.39) ALDH1A1DRD4KDM4EMAPT
SCHEMBL2807816 0.79 ALDH1A1 (0.32) ALDH1A1HSD17B10CYP3A4CYP2D6TSHR
SCHEMBL2803848 0.78 MAPT (0.46) ALDH1A1SMN1; SMN2DRD4KDM4EMAPT
SCHEMBL2806007 0.78 TLR9 (0.40) SMN1; SMN2POLBHTR1A
SCHEMBL2802561 0.78 POLB (0.47) ALDH1A1KMT2ALMNADRD4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 ALDH1A1 510/4885HSD17B10 2234/4885CYP3A4 1058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.